Actively Recruiting
Peri-implantitis Implantoplasty Treatment
Led by University of Oslo · Updated on 2026-04-29
35
Participants Needed
2
Research Sites
400 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This double arm, split-mouth, single centre, controlled, randomised clinical study is designed to examine the effect of implantoplasty in treatment of peri-implantitis. Peri-implantitis will be treated with open flap debridement, with or without implantoplasty.
CONDITIONS
Official Title
Peri-implantitis Implantoplasty Treatment
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosis of peri-implantitis on at least two implants with similar surface and defect type
- Ability to give informed consent
- Exposed and modified implant surface with bone loss greater than 2 mm
You will not qualify if you...
- Previous radiotherapy to the jaws, current chemotherapy, or long-term corticosteroid treatment
- Current or past bisphosphonate treatment
- Pregnant or nursing
- Classified above class II according to ASA classification
- Implant not suitable for implantoplasty treatment
- Unable to understand or complete the quality of life questionnaire
- Implant placement considered suboptimal and contributing to peri-implantitis
- History of peri-implantitis surgery within 6 months before screening
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Institute of Clinical Dentistry, Faculty of Dentistry, University of Oslo
Oslo, Oslo, Norway, 0455
Actively Recruiting
2
Institute of Clinical Dentistry, University of Oslo, Norway
Oslo, Norway
Actively Recruiting
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here